No | Title | Label | Acceptable range (%) |
1a. | Percentage of patients aged between 18 and 75 years with acute bronchitis/bronchiolitis (ICPC-2-R: R78) prescribed antibacterials for systemic use (ATC: J01) | (R78_J01_%) | 0–30 |
1b. | =1a receiving the recommended antibacterials (ATC: J01CA or J01AA) | (R78_RECOM_%) | 80–100 |
1c. | =1a receiving quinolones (ATC: J01M) | (R78_J01M_%) | 0–5 |
2a. | Percentage of patients older than 1 year with acute upper respiratory infection (ICPC-2-R: R74) prescribed antibacterials for systemic use (ATC: J01) | (R74_J01_%) | 0–20 |
2b. | =2a receiving the recommended antibacterials (ATC: J01CE) | (R74_RECOM_%) | 80–100 |
2c. | =2a receiving quinolones (ATC: J01M) | (R74_J01M_%) | 0–5 |
3a. | Percentage of female patients older than 18 years with cystitis/other urinary infection (ICPC-2-R: U71) prescribed antibacterials for systemic use (ATC: J01) | (U71_J01_%) | 80–100 |
3b. | =3a. receiving the recommended antibacterials (ATC: J01XE or J01EA or J01XX) | (U71_RECOM_%) | 80–100 |
3c. | =3a receiving quinolones (ATC: J01M) | (U71_J01M_%) | 0–5 |
4a. | Percentage of patients older than 1 year with acute tonsillitis (ICPC-2-R: R76) prescribed antibacterials for systemic use (ATC: J01) | (R76_J01_%) | 0–20 |
4b. | =4a receiving the recommended antibacterials (ATC: J01CE) | (R76_RECOM_%) | 80–100 |
4c. | =4a receiving quinolones (ATC: J01M) | (R76_J01M_%) | 0–5 |
5a. | Percentage of patients older than 18 years with acute/chronic sinusitis (ICPC-2-R: R75) prescribed antibacterials for systemic use (ATC: J01) | (R75_J01_%) | 0–20 |
5b. | =5a receiving the recommended antibacterials (ATC: J01CA or J01CE) | (R75_RECOM_%) | 80–100 |
5c. | =5a receiving quinolones (ATC: J01M) | (R75_J01M_%) | 0–5 |
6a. | Percentage of patients older than 2 years with acute otitis media/myringitis (ICPC-2-R: H71) prescribed antibacterials for systemic use (ATC: J01) | (H71_J01_%) | 0–20 |
6b. | =6a receiving the recommended antibacterials (ATC: J01CA or J01CE) | (H71_RECOM_%) | 80–100 |
6c. | =6a receiving quinolones (ATC: J01M) | (H71_J01M_%) | 0–5 |
7a. | Percentage of patients aged between 18 and 65 years with pneumonia (ICPC-2-R: R81) prescribed antibacterials for systemic use (ATC: J01) | (R81_J01_%) | 90–100 |
7b. | =7a receiving the recommended antibacterials (ATC: J01CA or J01AA) | (R81_RECOM_%) | 80–100 |
7c. | =7a receiving quinolones (ATC: J01M) | (R81_J01M_%) | 0–5 |
*Full name of the chemical subgroup according to the Anatomical Therapeutic Chemical (ATC) classification; J01AA, tetracyclines; J01CA, penicillins with extended spectrum; J01CE, beta-lactamase sensitive penicillins; J01EA, trimethoprim and derivatives; J01M, quinolone antibacterials; J01XE, nitrofuran derivatives; J01XX, other antibacterials.